Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | LYKALABS Lyka Labs Limited Pharma · Small | LOTUSEYE Lotus Eye Hospital and Institute Limited Pharma · Small | NATCAPSUQ Natural Capsules Limited Pharma · Small | MEDICO Medico Remedies Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 22 | 13 | 17 | 52 |
| Verdict | OVERVALUED | OVERVALUED | OVERVALUED | FAIR VALUE |
| Style | OVERVALUED | OVERVALUED | OVERVALUED | Financial Turnaround |
| Piotroski | 6/9 | 6/9 | 6/9 | 8/9 |
| Valuation | 5/30 | 1/30 | 5/30 | 8/30 |
| Growth | 6/25 | 4/25 | 7/25 | 14/25 |
| Quality | 0/20 | 0/20 | 0/20 | 14/20 |
| Balance Sheet | 7/15 | 4/15 | 7/15 | 10/15 |
| Cash Flow | 4/10 | 4/10 | 2/10 | 4/10 |
| Price | ₹70.05 | ₹122.39 | ₹158.85 | ₹43.42 |
| P/E | — | 3065.00 | — | 27.60 |
| P/B | 2.46 | 4.08 | 0.70 | 4.80 |
| ROE | -10.20% | 0.13% | -7.30% | 19.00% |
| ROCE | -6.10% | 1.16% | -4.76% | 23.10% |
| Debt / Equity | 0.53 | 0.26 | 0.49 | 0.25 |
| FCF Yield | — | — | — | 0.28% |
| Dividend Y | — | — | — | — |
| Altman Z | 2.96 | 7.71 | 1.88 | 5.25 |
| Promoter % | 58.16% | 40.14% | 51.04% | 61.38% |
| Mkt Cap (₹Cr) | 227.00 | 245.00 | 164.00 | 362.00 |
| Graham # | — | ₹5.1 | — | ₹17.99 |
| Fair PE | 8.7 | 1.0 | 10.7 | 42.0 |
| MoS % | — | -308965.7% | — | +34.6% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startLYKALABS47
LOTUSEYE183
NATCAPSUQ64
MEDICO75